Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:18:25.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision label also advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:47:05.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T23:02:58.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing visible content with an access-denied message and preventing access to the study details.
    Difference
    20%
    Check dated 2026-09-22T23:40:33.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6 label, reflecting a software version update.
    Difference
    0.0%
    Check dated 2026-09-16T00:07:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.6.6, replacing v3.6.5, indicating a minor update to the page's revision history. No substantive changes to the study details are described.
    Difference
    0.0%
    Check dated 2026-09-01T18:41:01.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.